Post-operative nausea and vomiting (PONV) is a common and often debilitating side-effect of surgery. It can be distressing for patients and can lead to longer hospital stays and increased costs. Fortunately, there are a number of innovative solutions available to help doctors overcome PONV and reduce its impact on their patients. In this article, we will take a look at the causes of PONV and explore some of the innovative solutions that doctors can use to reduce its incidence and impact.
Post-operative nausea and vomiting (PONV) is a common side-effect of surgery that can occur in up to 30% of patients. It is caused by the release of inflammatory mediators in the body in response to the trauma of surgery. It is characterized by nausea, vomiting, abdominal pain, and malaise. PONV can be distressing for patients and can lead to longer hospital stays and increased costs.
There are a number of factors that can increase the risk of PONV. These include the type of surgery, the type of anesthesia used, the patient’s age, gender, and medical history, the duration of the surgery, and the presence of other risk factors such as nausea and vomiting prior to surgery.
There are a number of strategies that doctors can use to reduce the risk of PONV. These include pre-operative antiemetic medications, the use of prophylactic antiemetics, and the avoidance of certain drugs and anesthetics that can increase the risk of PONV.
In addition to the traditional methods of preventing and treating PONV, there are a number of innovative solutions that doctors can use to reduce its incidence and impact. These include the use of virtual reality (VR) and augmented reality (AR) technology, the use of wearable devices, and the use of artificial intelligence (AI) to identify patients at risk of PONV.
Virtual reality (VR) and augmented reality (AR) technology can be used to create immersive, 3D environments that can help to distract patients from the nausea and vomiting associated with PONV. This can help to reduce the severity of the symptoms and can also help to reduce the need for antiemetic medications.
Wearable devices such as smartwatches and fitness trackers can be used to monitor patients for signs of PONV. These devices can detect changes in heart rate, temperature, and other vital signs that may indicate the onset of PONV. By monitoring these changes in real-time, doctors can intervene early and reduce the severity of the symptoms.
Artificial intelligence (AI) can be used to identify patients who are at risk of developing PONV. By analyzing a patient's medical history, demographics, and other factors, AI can identify patients who are likely to experience PONV and can alert doctors to intervene early.
Post-operative nausea and vomiting (PONV) is a common and often debilitating side-effect of surgery. Fortunately, there are a number of innovative solutions available to help doctors reduce its incidence and impact. These include the use of virtual reality (VR) and augmented reality (AR) technology, the use of wearable devices, and the use of artificial intelligence (AI) to identify patients at risk of PONV. By using these innovative solutions, doctors can help to reduce the severity of PONV and improve the quality of care for their patients.
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
Surgery may not be necessary to treat invasive breast cancer
5.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
1.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
2.
Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective
3.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
4.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
5.
Understanding Lymphedema: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation